Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER)

OBJECTIVE: Paliperidone extended-release tablet (paliperidone ER) is a new oral psychotropic agent developed for schizophrenia treatment. There have been some studies about paliperidone's good efficacy and tolerability. Clinicians appear to change the antipsychotic medication to paliperidone ER...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jung, Seung-Ho, Yoon, Jin-Sang, Ahn, Yong-Min, Kim, Yong-Sik, Kim, Chul-Eung
Format: Artigo
Idioma:Inglês
Publicat: Korean Neuropsychiatric Association 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902160/
https://ncbi.nlm.nih.gov/pubmed/24474991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2013.10.4.407
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars